Stefan Spinty

1.8k total citations
19 papers, 258 citations indexed

About

Stefan Spinty is a scholar working on Molecular Biology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stefan Spinty has authored 19 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Psychiatry and Mental health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stefan Spinty's work include Muscle Physiology and Disorders (5 papers), Epilepsy research and treatment (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). Stefan Spinty is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Epilepsy research and treatment (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). Stefan Spinty collaborates with scholars based in United Kingdom, United States and Australia. Stefan Spinty's co-authors include Rachel Kneen, Helen Roper, Ram Kumar, Imelda Hughes, R E Appleton, Amy McTague, Jonathon M. Tinsley, Gary Layton, Kay E. Davies and Francesco Muntoni and has published in prestigious journals such as PLoS ONE, Neurology and Archives of Disease in Childhood.

In The Last Decade

Stefan Spinty

17 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Spinty United Kingdom 10 123 86 73 46 46 19 258
Carina Cutmore Australia 5 87 0.7× 121 1.4× 35 0.5× 54 1.2× 75 1.6× 6 255
Yael Shiloh‐Malawsky United States 6 89 0.7× 78 0.9× 47 0.6× 40 0.9× 10 0.2× 13 214
Jung Hwan Lee South Korea 11 183 1.5× 83 1.0× 38 0.5× 58 1.3× 62 1.3× 29 391
Michele Iacomino Italy 11 169 1.4× 70 0.8× 54 0.7× 106 2.3× 16 0.3× 35 382
Benoît Rucheton France 7 117 1.0× 60 0.7× 36 0.5× 42 0.9× 7 0.2× 19 233
Judith Weisenberg United States 8 66 0.5× 122 1.4× 57 0.8× 56 1.2× 11 0.2× 18 270
Yasuhiro Suzuki Japan 8 122 1.0× 98 1.1× 61 0.8× 42 0.9× 17 0.4× 16 259
Ulla Enger Norway 11 266 2.2× 69 0.8× 55 0.8× 84 1.8× 237 5.2× 14 419
Susi Strozzi Switzerland 7 68 0.6× 27 0.3× 37 0.5× 30 0.7× 12 0.3× 11 180
Clara DM van Karnebeek Canada 7 190 1.5× 40 0.5× 32 0.4× 49 1.1× 9 0.2× 7 349

Countries citing papers authored by Stefan Spinty

Since Specialization
Citations

This map shows the geographic impact of Stefan Spinty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Spinty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Spinty more than expected).

Fields of papers citing papers by Stefan Spinty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Spinty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Spinty. The network helps show where Stefan Spinty may publish in the future.

Co-authorship network of co-authors of Stefan Spinty

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Spinty. A scholar is included among the top collaborators of Stefan Spinty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Spinty. Stefan Spinty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Childs, Anne‐Marie, Elizabeth Wraige, Pinki Munot, et al.. (2024). Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great Britain. Journal of Neuromuscular Diseases. 11(2). 361–368. 5 indexed citations
3.
Kelly, Maria D., et al.. (2024). Multidisciplinary Care for Moebius Syndrome and Related Disorders: Building a Management Protocol. Journal of Clinical Medicine. 13(11). 3309–3309. 1 indexed citations
5.
Bourke, John, Gillian Watson, Stefan Spinty, et al.. (2020). Preventing Cardiomyopathy in DMD. Neurology Clinical Practice. 11(5). e661–e668. 10 indexed citations
6.
Muntoni, Francesco, Stefan Spinty, Helen Roper, et al.. (2019). A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet. Clinical Pharmacology in Drug Development. 8(7). 922–933. 34 indexed citations
7.
Eyre, Michael, Yael Hacohen, Kate Lamb, et al.. (2019). Utility and safety of plasma exchange in paediatric neuroimmune disorders. Developmental Medicine & Child Neurology. 61(5). 540–546. 11 indexed citations
9.
Spinty, Stefan, Helen Roper, Imelda Hughes, et al.. (2017). Overcoming pharmacokinetic challenges to drug administration in Duchenne muscular dystrophy: Lessons from Phase 1 development of ezutromid. European Journal of Paediatric Neurology. 21. e93–e93. 1 indexed citations
11.
Hunt, Anne, et al.. (2016). Pain experience, expression and coping in boys and young men with Duchenne Muscular Dystrophy – A pilot study using mixed methods. European Journal of Paediatric Neurology. 20(4). 630–638. 19 indexed citations
12.
Tinsley, Jon, Francesco Muntoni, Stefan Spinty, et al.. (2015). Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Phase 1b Clinical Trial Results of SMT C1100 (P2.006). Neurology. 84(14_supplement). 1 indexed citations
13.
Piper, Joseph, et al.. (2014). Phenytoin dosing and serum concentrations in paediatric patients requiring 20 mg/kg intravenous loading. Archives of Disease in Childhood. 99(6). 585–586. 7 indexed citations
14.
Yesudian, Paul Devakar, Rita Cabral, E J Ladusans, et al.. (2014). Novel compound heterozygous mutations in thedesmoplakingene cause hair shaft abnormalities and culminate in lethal cardiomyopathy. Clinical and Experimental Dermatology. 39(4). 506–508. 5 indexed citations
15.
Thompson, Sarah, et al.. (2014). Dopa‐Responsive Dystonia and Chorea as a Presenting Feature in Ataxia‐Telangiectasia. Movement Disorders Clinical Practice. 1(3). 249–251. 10 indexed citations
16.
Piper, Joseph, et al.. (2014). G335(P) Phenytoin dosing and serum concentrations in paediatric patients requiring 20 mg/kg intravenous loading dose. Archives of Disease in Childhood. 99(Suppl 1). A138–A138. 1 indexed citations
17.
Littlewood, Robyn, Anand Iyer, G J Fellows, et al.. (2013). Spontaneous spinal epidural haematoma mimicking meningitis in a 2-year-old child—a case report and literature review. Child s Nervous System. 29(10). 1795–1798. 10 indexed citations
18.
Fong, Choong Yi, John Osborne, Stuart W. Edwards, et al.. (2013). An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Developmental Medicine & Child Neurology. 55(9). 862–867. 33 indexed citations
19.
McTague, Amy, Rachel Kneen, Ram Kumar, Stefan Spinty, & R E Appleton. (2012). Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: Experience from a children's hospital. Seizure. 21(7). 529–534. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026